Clinical trial: lansoprazole 15 or 30 mg once daily vs. placebo for treatment of frequent nighttime heartburn in self‐treating subjects [PDF]
, 2009 David A. Peura +3 more
openalex +1 more source
Results of a multicenter trial "Epidemiology of Gastroesophageal Reflux Disease in Russia" (MEGRE)
Терапевтический архив, 2011 Aim. To assess prevalence of gastroesophageal reflux disease (GERD) in Russia in MEGRE trial in 6 cities of the Russian Federatiion (Kazan, Kemerovo, Krasnoyarsk, Ryazan, St-Petersburg, Saransk). Material and methods.
Leonid Borisovich Lazebnik +19 more
doaj
Excess adipose and heartburn [PDF]
, 1997 W D B Clements, Paul Rice, Calum Harvey
openalex +1 more source
South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1998 Click on the link to view.
openaire +2 more sources
Prevalence and clinical aspects of Barrett’s esophagus in Khakasia republic
Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2010 Aim of investigation. To study prevalence and clinical aspects of Barrett’s esophagus at native and extraterrestrial inhabitants of Khakasia republic.Material and methods.
N. N. Butorin +4 more
doaj
Social and medical impact, sleep quality and the pharmaceutical costs of heartburn in Taiwan [PDF]
, 2005 Ching‐Liang Lu +6 more
openalex +1 more source
Tegaserod significantly improves esophageal mechanical pain threshold, regurgitation, and global preference vs. placebo in patients with functional heartburn [PDF]
, 2004 Sheila Rodriguez-Stanley +5 more
openalex +1 more source
Some issues of the diagnosis and treatment of gastroesophageal reflux disease
Терапевтический архив, 2015 The clinical inefficacy of proton pump inhibitors (PPIs) is very frequently encountered in nonerosive gastroesophageal reflux disease (NERD) in particular. Postprandial acid pocket, weak-acid or alkaline reflux, etc.
V G Avdeev
doaj
Prevalence of non-obstructive dysphagia in patients with heartburn and regurgitation
, 2020 Andrea Oliveira Batista +6 more
openalex +1 more source